From the World's first total replacement heart pump to the World's smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous VADs. The range includes the Impella® 2.5, which at 1/100th the size of the heart is the only percutaneous hemodynamic support device that is proven safe and effective by the FDA for high risk percutaneous coronary intervention (PCI) procedures.